AC Immune SA
For the period ended Dec 31, 2025. Filed Mar 13, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Mar 13, 2026
Contents
B. Significant changes
A discussion of the significant changes in our business can be found under “Item 4. Information on the Company—A. History and development of the Company,” “Item 4. Information on the Company—B. Business overview,” and Note 23Subsequent Events, included in the audited consolidated financial statements starting at page F-1. Other than the events included in these places, no significant changes have occurred.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.